Successful scale-up and scale out is essential when bringing advanced therapies to market. It is critical to create a reproducible, reliable, and predictable scale-up strategy, while preserving the integrity of the culture, moving efficiently, and keeping costs low.
Corning’s adherent and suspension expansion platforms streamline your production-level scale-up, without sacrificing yield, quality, or viability.
Discover Corning’s new Ascent Fixed Bed Reactor (FBR) System, specifically designed to combine the yield efficiency, flexibility, and viable cell harvest of adherent bioproduction platforms, with the scale and automation of suspension manufacturing systems.
If you’d like to see the Corning Ascent FBR System in action, please contact us to request a demonstration
Blog Series
Support
With more than 100 years of experience in life sciences, Corning deeply understands the importance of quality. We offer:
Our tried and true manufacturing processes and practices are designed to ensure that every product delivers consistent, reliable results.
With more than 100 years of experience in life sciences, Corning deeply understands the importance of quality. We offer:
Our tried and true manufacturing processes and practices are designed to ensure that every product delivers consistent, reliable results.
